Wetherby Asset Management Inc. Acquires 320 Shares of Regeneron Pharmaceuticals, Inc.


Wetherby Asset Management Inc. raised its stake in shares of Regeneron Pharmaceuticals, Inc. by 25.4% during the second quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 1,580 shares of the biopharmaceutical company's stock after buying an additional 320 shares during the period.



from Biotech News